Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yair Safriel

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Pain Physician|January 2, 2026
Impact of Lead-shielding on the Utilization of Magnetic Resonance Imaging Among Patients with Spinal Cord Stimulation Systems: A Study of Retrospective Claims in the USYair Safriel, Nomen Azeem, Samir Sheth, et al.
Spine|February 4, 2015
The rate of magnetic resonance imaging in patients with spinal cord stimulationMehul J Desai, Liesl M Hargens, Maria D Breitenfeldt, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|January 7, 2009
Clinical and radiological outcome of anterior-posterior fusion versus transforaminal lumbar interbody fusion for symptomatic disc degeneration: a retrospective comparative study of 133 patientsAntonio A Faundez, James D Schwender, Yair Safriel, et al.
Radiology|November 28, 2018
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 StudyDaniel P Barboriak, Zheng Zhang, Pratikkumar Desai, et al.
Neuro-Oncology|March 29, 2018
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686Jerrold L Boxerman, Zheng Zhang, Yair Safriel, et al.
Neuro-Oncology|June 22, 2013
Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader StudyJerrold L Boxerman, Zheng Zhang, Yair Safriel, et al.
Heart Rhythm|October 8, 2013
Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modelingBruce L Wilkoff, Timothy Albert, Mariya Lazebnik, et al.
Neuro-Oncology|May 7, 2013
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677Eva-Maria Ratai, Zheng Zhang, Bradley S Snyder, et al.
International Journal of Oncology|February 13, 2015
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastomaBenjamin M Ellingson, Eunhee Kim, Davis C Woodworth, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Pain Physician|January 2, 2026
Impact of Lead-shielding on the Utilization of Magnetic Resonance Imaging Among Patients with Spinal Cord Stimulation Systems: A Study of Retrospective Claims in the USYair Safriel, Nomen Azeem, Samir Sheth, et al.
Spine|February 4, 2015
The rate of magnetic resonance imaging in patients with spinal cord stimulationMehul J Desai, Liesl M Hargens, Maria D Breitenfeldt, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|January 7, 2009
Clinical and radiological outcome of anterior-posterior fusion versus transforaminal lumbar interbody fusion for symptomatic disc degeneration: a retrospective comparative study of 133 patientsAntonio A Faundez, James D Schwender, Yair Safriel, et al.
Radiology|November 28, 2018
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 StudyDaniel P Barboriak, Zheng Zhang, Pratikkumar Desai, et al.
Neuro-Oncology|March 29, 2018
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686Jerrold L Boxerman, Zheng Zhang, Yair Safriel, et al.
Neuro-Oncology|June 22, 2013
Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader StudyJerrold L Boxerman, Zheng Zhang, Yair Safriel, et al.
Heart Rhythm|October 8, 2013
Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modelingBruce L Wilkoff, Timothy Albert, Mariya Lazebnik, et al.
Neuro-Oncology|May 7, 2013
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677Eva-Maria Ratai, Zheng Zhang, Bradley S Snyder, et al.
International Journal of Oncology|February 13, 2015
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastomaBenjamin M Ellingson, Eunhee Kim, Davis C Woodworth, et al.
Pageof 2